by Jordana Choucair | Jun 15, 2022 | Life Sciences
A Food and Drug Administration (FDA) advisory panel voted 22-0 to recommend the agency expand the authorization of Moderna’s COVID-19 vaccine to children and teenagers ages 6 to 17. An FDA analysis estimated that the vaccine was 93 percent effective for teens and 77...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
Senator Amy Klobuchar and Representative Katie Porter asked the Federal Trade Commission (FTC) to investigate whether Janssen Pharmaceuticals and Bristol Myers Squibb Co. coordinated “parallel” price increases on Xarelto and Eliquis. The letter noted that,...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first treatment for alopecia treatment that restores hair growth. The agency said that two trials showed that Eli Lilly & Co.’s Olumiant helped roughly 40 percent of the 1,2000 trial participants achieve...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
An amendment to the Senate’s latest FDA user fee proposal calls on infant formula manufacturers to notify the agency within five business days of a disruption to their supply chain, an attempt to better guard against future formula shortages. The amendment...
by Jordana Choucair | Jun 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) released briefing documents indicating that Moderna’s and Pfizer-BioNTech’s COVID-19 vaccines are both effective and safe for children 5 years old and younger. The FDA documents found that the Pfizer-BioNTech vaccine was...
by Jordana Choucair | Jun 13, 2022 | Life Sciences
The Biden administration is eyeing a policy change to push tobacco companies to cut nicotine levels in cigarettes sold in the U.S. to nonaddictive levels. The move would be the government’s biggest step to curb smoking since the Master Settlement Agreement in 1998....
Recent Comments